6 Recommendations for research


The Assessment Group considered that the following well-conducted RCTs reporting health-related utility values in accordance with the NICE methods guide could be of value:

  • RCTs to investigate the effectiveness of sunitinib compared with best supportive care in people who are unsuitable or have contraindications for immunotherapy and who have a poor or intermediate prognosis.


The Committee considered that rigorous data collection is needed on the life-extending benefits of sunitinib when no second-line treatments are given.

  • National Institute for Health and Care Excellence (NICE)